Javascript must be enabled to continue!
Potential of Levofloxacin and Ciprofloxacin against citrus canker caused by Xanthomonas axonopodis pv. citri
View through CrossRef
Citrus canker caused by Xanthomonas axonopodis pv. citri (Xac) is the most devastating threat to the world citrus industry. A greenhouse and field trail were conducted at Department of Plant Pathology, University of Agriculture Faisalabad. Levofloxacin, Ciprofloxacin were tested against Xac by injection technique under Randomized Complete Block Design (RCBD). Three concentrations (1, 1.5 and 2 %) after 10, 20, and 30 days were tested. Out of these treatments, combination of Levofloxacin and Ciprofloxacin (14.51 %) followed by Levofloxacin 17.48 %, Ciprofloxacin (21.66 %), in greenhouse respectively. In interaction between treatments and concentrations, combination of Levofloxacin and Ciprofloxacin expressed minimum disease incidence (10.44 %) at 2 % and 9.278 % after 30 days of inoculation in the interaction between treatments and days. In field study, combination of Levofloxacin and Ciprofloxacin (17.51 %) followed by Levofloxacin 20.48 %, Ciprofloxacin (24.09 %), and control (64.00 %) respectively. Interaction between treatments and concentrations, combination of Levofloxacin and Ciprofloxacin expressed minimum disease incidence (13.44 %) at 2 % while in interaction between treatments and days, this combination showed (12.27 %) disease incidence followed by Levofloxacin 15.27 % and Ciprofloxacin 17.22 % and control 69.11 % after 30 days of inoculation. In conclusion, combination of Ciprofloxacin and Levofloxacin expressed best results at concentration of 2 % after 30 days of inoculation.
Title: Potential of Levofloxacin and Ciprofloxacin against citrus canker caused by Xanthomonas axonopodis pv. citri
Description:
Citrus canker caused by Xanthomonas axonopodis pv.
citri (Xac) is the most devastating threat to the world citrus industry.
A greenhouse and field trail were conducted at Department of Plant Pathology, University of Agriculture Faisalabad.
Levofloxacin, Ciprofloxacin were tested against Xac by injection technique under Randomized Complete Block Design (RCBD).
Three concentrations (1, 1.
5 and 2 %) after 10, 20, and 30 days were tested.
Out of these treatments, combination of Levofloxacin and Ciprofloxacin (14.
51 %) followed by Levofloxacin 17.
48 %, Ciprofloxacin (21.
66 %), in greenhouse respectively.
In interaction between treatments and concentrations, combination of Levofloxacin and Ciprofloxacin expressed minimum disease incidence (10.
44 %) at 2 % and 9.
278 % after 30 days of inoculation in the interaction between treatments and days.
In field study, combination of Levofloxacin and Ciprofloxacin (17.
51 %) followed by Levofloxacin 20.
48 %, Ciprofloxacin (24.
09 %), and control (64.
00 %) respectively.
Interaction between treatments and concentrations, combination of Levofloxacin and Ciprofloxacin expressed minimum disease incidence (13.
44 %) at 2 % while in interaction between treatments and days, this combination showed (12.
27 %) disease incidence followed by Levofloxacin 15.
27 % and Ciprofloxacin 17.
22 % and control 69.
11 % after 30 days of inoculation.
In conclusion, combination of Ciprofloxacin and Levofloxacin expressed best results at concentration of 2 % after 30 days of inoculation.
Related Results
Characterization of Xanthomonas spp. strains by bacteriocins
Characterization of Xanthomonas spp. strains by bacteriocins
Twenty-five strains of Xanthomonas axonopodis pv. citri and 14 strains of Xanthomonas spp. were tested for bacteriocin production. X. axonopodis pv. passiflorae strains were sensit...
Phyto-extracts Mediated Biological Control of Citrus Canker
Phyto-extracts Mediated Biological Control of Citrus Canker
Citrus is second most important fruit crop and has significance economic importance in Pakistan. In Pakistan 2.17 million tonnes citrus was produced on area of 1.94 million acre. C...
Citrus Canker—Distribution, Taxonomy, Epidemiology, Disease Cycle, Pathogen Biology, Detection, and Management: A Critical Review and Future Research Agenda
Citrus Canker—Distribution, Taxonomy, Epidemiology, Disease Cycle, Pathogen Biology, Detection, and Management: A Critical Review and Future Research Agenda
Xanthomonas citri subsp. citri, a causative agent of the citrus canker (CC) disease, belongs to one of the essential groups of the bacterial phytopathogen family, Xanthomonadaceae....
Citrus Canker: Developments down the lane
Citrus Canker: Developments down the lane
Citrus canker (caused by Xanthomonas citri ssp.citri , a gram negative bacterium) is considered one of the most feared bacterial diseases of limes/lemons, though affects all typ...
Biochemical characterization of Xanthomonas axonopodis pv. citri; A major impediment to Citrus orchards
Biochemical characterization of Xanthomonas axonopodis pv. citri; A major impediment to Citrus orchards
Citrus is a significant crop playing an important role in Pakistan’s economy. However, its production is under constant threat by numerous pathogens resulting in considerable econo...
Insights into xanthomonas axonopodis pv. citri biofilm through proteomics
Insights into xanthomonas axonopodis pv. citri biofilm through proteomics
Abstract
Background
Xanthomonas axonopodis pv. citri (X. a. pv. citri) causes citrus canker that can result in defoliation and pre...
Efficacy of antibiotics and bactericides against Xanthomonas axonopodis pv. citri causing bacterial canker disease of acid lime (Citrus aurantifolia)
Efficacy of antibiotics and bactericides against Xanthomonas axonopodis pv. citri causing bacterial canker disease of acid lime (Citrus aurantifolia)
Diseases are the major constraints for citrus production which impede the fruit yield and quality. Citrus suffers from a number of diseases caused by fungi, bacteria, viruses and v...
Population Pharmacokinetics and Penetration into Prostatic, Seminal, and Vaginal Fluid for Ciprofloxacin, Levofloxacin, and Their Combination
Population Pharmacokinetics and Penetration into Prostatic, Seminal, and Vaginal Fluid for Ciprofloxacin, Levofloxacin, and Their Combination
<i>Background:</i> Our objectives were to assess the pharmacokinetic interaction and body fluid penetration of ciprofloxacin and levofloxacin. <i>Methods:</i&g...

